Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women

SUMMARY: Follow-up raloxifene therapy after denosumab discontinuation resulted in a decrease in bone mass to the pre-denosumab levels and a rebound increase of bone turnover markers. The decrease in lumbar bone mineral density was particularly evident when the body mass index was low, there were pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, J., Kim, J., Jeong, C., Lim, Y., Kim, M. K., Kwon, H.-S., Song, K.-H., Kang, M. I., Baek, K.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978765/
https://www.ncbi.nlm.nih.gov/pubmed/35376989
http://dx.doi.org/10.1007/s00198-022-06388-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978765/
https://www.ncbi.nlm.nih.gov/pubmed/35376989
http://dx.doi.org/10.1007/s00198-022-06388-w

Ejemplares similares